Back to Annual Meeting Page
133rd Annual Meeting & Exposition
December 10-14, 2005
Grace L. Reynolds, DPA, Dennis G. Fisher, PhD, Adi Jaffe, BA, Christine Willey, MA, and Diana Fernandez, BS. Center for Behavioral Research & Services, California State University, Long Beach, 1090 Atlantic Avenue, Long Beach, CA 90813, 562-495-2330, email@example.com
Objective: To explore the association between risky injection and hygiene practices, and hepatitis A, B, and C infection, in injection drug users.
Methods: The Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ) was used to elicit information from 388 current and former injection drug users (IDUs) on their injection and hygiene practices. Data from the BBV-TRAQ were linked to participants' blood test results. Demographic information was obtained from the Risk Behavior Assessment (RBA).
Results: 49% of participants tested positive for HAV, 52% for HBV and 71% for HCV. HAV negative individuals were more likely to report rinsing with bleach if they used another person's used needle/syringe (Χ2(1, n = 60) = 4.53, p = .03); and were more likely to wash their hands if they touched their injection site (to stop bleeding) after assisting another person with their injection (Χ2(1, n = 47) = 7.31, p = .0068). For HBV negative participants, when another person touched their injection site (to stop bleeding) they were more likely to wash their hands before doing so (Χ2(1, n = 38) = 9.73, p = .0018). HCV negatives were more likely to report cleaning the spoon prior to use if they injected drugs prepared with someone else's spoon (Χ2(1, n = 357) = 9.48, p = .0021).
Conclusions: Avoidance of risky injection and hygiene practices is associated with negative test results for hepatitis A, B, and C. Specific risky practices may be linked to specific hepatitis infections.
Keywords: Injection Drug Users, Hepatitis C
Presenting author's disclosure statement:
I wish to disclose that I have NO financial interests or other relationship with the manufactures of commercial products, suppliers of commercial services or commercial supporters.
The 133rd Annual Meeting & Exposition (December 10-14, 2005) of APHA